Coronavirus Disease 2019 (COVID-19) and the Kidney – Biosampling as part of the BIOMASOTA-Biobank
Recruiting
- Conditions
- Kidney diseasesU07.1COVID-19, virus identified
- Registration Number
- DRKS00024702
- Lead Sponsor
- Klinik II für Innere Medizin Uniklinik Köln
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2500
Inclusion Criteria
clinical suspicion of COVID-19 infection
Exclusion Criteria
Lack of ability of consent, lack of concent to BioMaSOTA (Biobanking of Institute for Pathology, University of Cologne)
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biosampling (serum, urine, stool, saliva and tissue samples ) within the BioMaSoTa project of the Institute of Pathology of the University Hospital of Cologne in patients with clinical suspicion of SARS-CoV-2 infection to analyzed, whether there are the factors, which have an influence on the renal involvement in COVID-19, whether there are molecular biological factors, that predispose to renal involvement in COVID-19 infection (e.g. hematuria, proteinuria, acute renal injury).
- Secondary Outcome Measures
Name Time Method